Summary of the information presented in AAMI TIR No. 14 – 2009, Contract Sterilization Using Ethylene Oxide
The Association for the Advancement for Medical Instrumentation (AAMI) provides several guidance documents to augment ANSI/AAMI/ISO 111351, – Sterilization of health care products – Ethylene oxide – Requirements for development, validation, and routine control of a sterilization process for medical devices. One such document is AAMI TIR No. 14 – 20092, Contract Sterilization Using Ethylene Oxide. Within this document, much attention is given to the written agreement established between a product manufacturer and a contract sterilization supplier. The following is a summary of the information presented in the TIR.
Before starting contract sterilization processing, a written agreement that outlines the services to be provided by both parties should be developed and approved. Requirements for the agreement between two parties are found in 21 Code of Federal Regulation 801.150(e)3. This section of the regulations requires a written contract when interstate shipping is involved. For intrastate services, a contract is recommended to ensure compliance with the GMP requirements for device master records (21 CFR 820.181)4. The regulation specifies the contents of the agreement, including a requirement for a detailed delineation of the sterilization process. It is necessary to examine the contract sterilizer’s compliance with this regulation. In addition to the requirements of 21 CFR 801.150, good business practices may require other inclusions in the written agreement to clarify the division of responsibilities.
The written agreement may be in the form of a formal business contract or in the form of internal Standard Operating Procedures (SOPs) that are signed by both parties. The written agreement shall, directly or by reference to existing documents, indicate the responsibilities of each party for assuring the completion of all GMP requirements related to the sterilization process. For ethylene oxide sterilization, the written agreement should contain or reference the following:
The agreement should specify the individuals at each facility responsible for coordinating the flow of information between establishments and for approving procedural changes.
The agreement should specify all required documentation (for example: procedures, processing records) to be used and maintained. Both parties should agree on the manner in which documentation changes are to be made.
The written agreement should specify all parameters to be qualified by the contractor and the criteria for re-qualification.
The agreement should specify the pallet patterns, vessel loading configuration, packaging, and whether the load is pre-wrapped or shrink-wrapped for each product or product family.
Biological Indicators and Product Test Samples
The agreement should specify responsibility for placement, retrieval, handling, processing, and maximum time intervals before shipment of BIs and product test samples. It should include instructions for packaging and shipment of BIs and product test samples to test laboratories for analysis.
Cycle Parameters and Process Control
The agreement should specify the process parameters and the allowable limits that should be achieved for sterilization once the sterilization process has been validated.
The agreement should specify procedures for post-sterilization quarantine of the product before release for distribution.
Batch Records and Review
The agreement should specify procedures and responsibility for approving sterilization batch records prior to release.
Finished Product Release
The agreement should specify product release procedures and identify the individuals who are responsible for approving release for distribution.
The agreement should specify the scope of audits, corrective actions, documentation or audit, and confidentiality.
Control of Changes, Process Deviations, and Product Damage
The agreement should specify the individuals to be notified of any changes or deviations in the manufacturing or sterilization process. It should also specify the individual at the manufacturer or manufacturing facility that should be contacted when product is damaged to determine how the product should be handled at the contract sterilizer.
Reprocessing of Loads
The agreement shall specify how reprocessing procedures are established, implemented, and controlled to assure that the reprocessing steps and product meet the validation and routine processing specification criteria.
Material Handling and Documentation
Adherence to Title 21, CFR, Part 801.150 is required for label control. The agreement should specify how adherence is to be controlled/conducted.
Contract Agreement Criteria
The written agreement shall specify all shipping arrangements including labeling for shipping and should identify laboratories to be used for sample testing. The contract is a valuable tool to assure sterilization consistency and regulatory compliance, and to help prevent misunderstandings between the parties. It binds both parties to the procedures and agreements which control all aspects of the sterilization process.
- ANSI/AAMI/ISO 11135, 2007 – Sterilization of health care products – Ethylene oxide – Requirements for development, validation, and routine control of a sterilization process for medical devices
- AAMI Technical Information Report (TIR) No. 14 – Contract Sterilization Using Ethylene Oxide, 2009
- 21 CFR Part 801.150(e): Medical devices, processing, labeling, or re-packing – 1996
- 21 CFR Part 820 Medical Devices; Current Good Manufacturing Practice (CGMP) – 1996
Study on the Impact of EO Concentration on Product Residuals
A study was carried out to compare the impact, if any, of EO concentration on product EO residual levels determined in accordance with ISO10993-7.
Sustainable EO® Frequently Asked Questions
As part of our commitment to providing innovative and sustainable solutions, STERIS AST has developed the Sustainable EO® sterilization services program.
Overview Of Sterilization Technology Comparison
Learn more about our global offering, which includes electron beam, gamma, X-ray, and ethylene oxide technologies
Selection of Appropriate Internal Process Challenge Devices (PCDs)
This TechTip provides a summary of minimizing over-processing by understanding how to establish an appropriate internal process challenge device. Let our team review your process and identify other ways to help reduce EO sterilant used through our Sustainable EO® sterilization services